These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24452985)

  • 1. Melanonychia and mucocutaneous hyperpigmentation from hydroxyurea use for the treatment of essential thrombocytosis.
    Karanth SS; Gupta A; Prabhu M
    Singapore Med J; 2014 Jan; 55(1):e7-8. PubMed ID: 24452985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal, transverse, and diffuse nail hyperpigmentation induced by hydroxyurea.
    Hernández-Martín A; Ros-Forteza S; de Unamuno P
    J Am Acad Dermatol; 1999 Aug; 41(2 Pt 2):333-4. PubMed ID: 10426924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nail pigmentation caused by hydroxyurea: report of 9 cases.
    Aste N; Fumo G; Contu F; Aste N; Biggio P
    J Am Acad Dermatol; 2002 Jul; 47(1):146-7. PubMed ID: 12077597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal melanonychia associated with hydroxyurea therapy in a patient with essential thrombocytosis.
    Cohen AD; Hallel-Halevy D; Hatskelzon L; Peretz E; Halevy S
    J Eur Acad Dermatol Venereol; 1999 Sep; 13(2):137-9. PubMed ID: 10568495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Longitudinal melanonychia and hydroxyurea].
    Pirard C; Michaux JL; Bourlond A
    Ann Dermatol Venereol; 1994; 121(2):106-9. PubMed ID: 7979014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nail pigmentation due to hydroxycarbamide.
    Ceulen RP; Frank J; Poblete-Gutiérrez P
    Int J Dermatol; 2007 Nov; 46 Suppl 3():13-5. PubMed ID: 17973880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyurea-induced nail pigmentation.
    Kwong YL
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):275-6. PubMed ID: 8708039
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydroxyurea associated with concomitant occurrence of diffuse longitudinal melanonychia and multiple squamous cell carcinomas in an elderly subject.
    Saraceno R; Teoli M; Chimenti S
    Clin Ther; 2008 Jul; 30(7):1324-9. PubMed ID: 18691992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal melanonychia in a patient with essential thrombocytosis under treatment with hydroxyurea.
    Clerico R; Corsetti P; Ambrifi M; Paolino G; Rossi MR; Bottoni U; Calvieri S
    Acta Dermatovenerol Croat; 2012; 20(4):281-3. PubMed ID: 23317494
    [No Abstract]   [Full Text] [Related]  

  • 10. Melanonychia and mucocutaneous hyperpigmentation due to hydroxyurea use in an HIV-infected patient.
    Laughon SK; Shinn LL; Nunley JR
    Int J Dermatol; 2000 Dec; 39(12):928-31. PubMed ID: 11168664
    [No Abstract]   [Full Text] [Related]  

  • 11. Mucocutaneous lesions and nail pigmentation in a patient with essential thrombocytosis.
    Calleja Algarra A; Miguel RA; Tous Romero F; Maroñas Jiménez L
    Aust Fam Physician; 2017; 46(4):222-224. PubMed ID: 28376576
    [No Abstract]   [Full Text] [Related]  

  • 12. Twenty-Nail Transverse Melanonychia Induced by Hydroxyurea: Case Report and Review of the Literature.
    Osemwota O; Uhlemann J; Rubin A
    J Drugs Dermatol; 2017 Aug; 16(8):814-815. PubMed ID: 28809997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of hydroxyurea-induced transverse melanonychia.
    Teo RY; Tan E
    Int J Dermatol; 2006 Nov; 45(11):1329-30. PubMed ID: 17076717
    [No Abstract]   [Full Text] [Related]  

  • 14. Transverse melanonychia and palmar hyperpigmentation secondary to hydroxyurea therapy.
    Schoenfeld J; Tulbert BH; Cusack CA
    Cutis; 2017 May; 99(5):E2-E4. PubMed ID: 28632807
    [No Abstract]   [Full Text] [Related]  

  • 15. Toenails melanonychia induced by hydroxyurea.
    Kluger N; Naud M; Françès P
    Presse Med; 2012 Apr; 41(4):444-5. PubMed ID: 21996473
    [No Abstract]   [Full Text] [Related]  

  • 16. Subungual melanoma complicated by hydroxyurea-induced melanonychia with non-melanoma Hutchinson's sign.
    Saito A; Fujisawa Y; Maruyama H; Nakamura Y; Ishitsuka Y; Watanabe R; Okiyama N; Fujimoto M
    Eur J Dermatol; 2018 Aug; 28(4):559-561. PubMed ID: 29941409
    [No Abstract]   [Full Text] [Related]  

  • 17. Cutaneous manifestations of hydroxyurea therapy in childhood: case report and review.
    Issaivanan M; Mitu PS; Manisha C; Praveen K
    Pediatr Dermatol; 2004; 21(2):124-7. PubMed ID: 15078351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal melanonychia and subungual hemorrhage in a patient with systemic lupus erythematosus treated with hydroxychloroquine.
    Zhang S; Liu X; Cai L; Zhang J; Zhou C
    Lupus; 2019 Jan; 28(1):129-132. PubMed ID: 30428763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyurea-Induced Oral Hyperpigmentation: A Case Report and Review of the Literature.
    Veillet-Lemay G; Haber RM
    J Cutan Med Surg; 2019; 23(1):111-113. PubMed ID: 30232899
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous adverse reactions to hydroxyurea in patients with intermediate thalassemia.
    Zargari O; Kimyai-Asadi A; Jafroodi M
    Pediatr Dermatol; 2004; 21(6):633-5. PubMed ID: 15575845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.